At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Water-only Fastingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients
In Brief
A clinical study evaluating Water-only Fasting for Hypertension. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This purpose of this study is to examine the safety and feasibility of water-only fasting to treat hypertensive patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartAug 2020
First PostedAug 2020
Primary CompletionSep 2021
Study CompletionDec 2022
TodayJul 2026
First PostedAug 17, 2020
Enrollment StartAug 16, 2020
Primary CompletionSep 29, 2021
Study CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.9 years ago
Interventions
Water-only Fastingother
Participants consume only water for at least 7 days in an in-patient, residential setting with 24 hour medical supervision.